Interestingly, it has been recently shown that antibodies against TDP-43 RRM1, able to disrupt this interaction, can reduce the neuroinflammation and the motor defects in mice that express an ALS-linked TDP-43 mutation [178]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.